Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study.
BACKGROUND AND AIMS:There is limited data on hepatitis C (HCV) treatment uptake among people who inject drugs including individuals receiving opioid substitution treatment (OST). We aimed to calculate cumulative HCV treatment uptake, estimate annual treatment rates, and identify factors associated w...
Main Authors: | Håvard Midgard, Jørgen G Bramness, Svetlana Skurtveit, John W Haukeland, Olav Dalgard |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5112941?pdf=render |
Similar Items
-
Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV).
by: Lars T Fadnes, et al.
Published: (2021-06-01) -
Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)
by: Lars T. Fadnes, et al.
Published: (2019-11-01) -
Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017
by: Christer F. Aas, et al.
Published: (2020-06-01) -
Mortality and cause of death in patients with heroin dependence receiving opioid substitution treatment (OST)
by: Kun-ChiaChang, et al.
Published: (2013) -
The role of pharmacoepidemiological studies in the market withdrawal of carisoprodol (Somadril®) in Europe
by: Jørgen G. Bramness, et al.